SEC Form 4 · accession 0001470831-26-000627
BridgeBio Pharma, Inc. · BBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank McCormick
Director
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 6:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001743881
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3,F4 | Jun 22, 2026 | A | 3,990 | $0.00 | A | 10,579 | D | |
| Common StockF3,F5 | holding | — | — | — | 756,665 | I | By the Francis P. McCormick Rev Trust U/A DTD 1/27/2017 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6 | $68.92 | Jun 22, 2026 | A | 5,277 | A | — | Jun 21, 2036 | Common Stock | 5,277 | 5,277 | D |
Explanation of responses
- F1Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.
- F2Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- F3The Reporting Person previously reported a transfer of 352,290 shares on a Form 4 filed June 25, 2024. The reported transfer did not occur, and no change in beneficial ownership took place at that time. The ownership amounts reported herein reflect the Reporting Person's correct holdings and the transfer described in Footnotes 4 and 5.
- F4Excludes 428,976 shares that were previously held directly by the Reporting Person and were transferred to the Reporting Person's trust account on June 3, 2026.
- F5Includes 428,976 shares that were previously held directly by the Reporting Person and were transferred to the Reporting Person's trust account on June 3, 2026.
- F6The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date.